Precision BioSciences

Biotech & Life Sciences · Durham, United States · Founded 2006 · IPO 2019

A gene editing company specializing in in vivo gene editing with its ARCUS platform

Valuation $85M

Revenue $19M

Power Law Thoroughbred$100M+ revenue

Talent graph

Precision BioSciences's talent

Book a demo to see the people

Employees mapped 97 incl. 2 AI specialists

Founders /100 quality score

Key operators 31 quality /100

Potential founders likely future founders

Startup mafia 4 alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

18 investors on Precision BioSciences's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 8 investors entered at this stage

Longevity Fund

F-Prime

Baxter Ventures

venBio Partners

Ziegler Group

RA Capital Management

Osage University Partners

Amgen Ventures

Series B+ 10 investors entered at this stage

Vivo Capital

Alexandria Venture Investments

Transformation Capital

Adage Capital

ArrowMark Partners

Cormorant Asset Management

Franklin Templeton Investments

Pontifax AgTech

Agent Capital

Brace Pharma

Precision BioSciences mafia

Startups founded by Precision BioSciences alumni

Former Precision BioSciences employees who went on to start their own companies. Sorted by Dealroom signal score.

Cumulus Digital SystemsEst. 2018

Matthew KleimanUnited States

Signal score70

TraitologyEst. 2022

Fayaz Khazi, Ph.D.United States

Signal score66

Elo Life SystemsEst. 2021

Derek JantzUnited States

Signal score63

Archean BiologicsEst. 2020

David ThomsonUnited States

Signal score46

Book a demo to explore the full alumni network →

Global footprint

Where Precision BioSciences has talent and traffic

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Web traffic by country

7.7K monthly visits
across markets

🇺🇸 United States70.1%

🇩🇪 Germany9.1%

🇮🇳 India9.1%

🇯🇵 Japan6.5%

🇨🇦 Canada6.5%

Top 5 markets shown

Patent intelligence

$71M patent portfolio · 38 active families

Estimated portfolio value

$71M

83.4% of market cap · 13.5× larger than top peer Zymergen ($5M)

38 active patent families

Where Precision BioSciences innovates BioinformaticsCancer researchCellCell biologyMeganuclease

Where Precision BioSciences concentrates vs peers

Each axis is a top-10 topic across Precision BioSciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Precision BioSciences

An AI-synthesized read of the highest-engagement posts about Precision BioSciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Precision BioSciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles